Why This Stock Could Be a Better Bargain Than Aurora Cannabis (TSX:ACB)

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) may have fallen significantly in value this year, but that still doesn’t make the stock a cheap buy.

| More on:

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) has taken a beating over the past 12 months, losing more than 40% of its value during that time. You have to go back around two years for the last time that the stock traded this low.

And yet, a great deal has changed since then and the company has grown a great deal. Not only does Aurora have a presence in many countries worldwide, but it’s also generated more than $168 million in sales over the past four quarters.

The cannabis company has come a long way, and with the launch of the cannabis 2.0 market right around the corner, the next 12 months could continue to build on its impressive growth.

Unfortunately, it’s the company’s lack of profitability has been weighing on investors, with losses totalling $211 million over the past four quarters sticking out like a sore thumb for many potential buyers. Coupled with that and a lack of cash flow garnering more of the spotlight lately, it’s no wonder the stock been beaten up so badly.

Smaller cannabis stock could generate better returns

As badly as Aurora has performed over the past year and as cheap as the stock may seem, trading at 20 times its sales, it may not be the cheapest buy for cannabis investors today. Namaste Technologies Inc (TSXV:N) is at a market cap of around $130 million and is still a relatively smaller player on the cannabis stage.

With a price-to-sales ratio of just seven, investors are paying even less of a premium to own Namaste. While it definitely has less brand recognition than Aurora, it still has a lot of potential to rise in value, perhaps even more.

One of the benefits of investing in a smaller stock is that there’s a lot more upside for investors to benefit from. Entering the week trading at just $0.40 at writing, it wouldn’t take a lot for Namaste to double or even triple in value, and it could still be a cheap stock to own.

Similar to Aurora, Namaste has also struggled with profitability, albeit its losses have not been early as significant. During the first six months of the fiscal year, Namaste accumulated $19 million in losses.

While it’s still an issue, without the breadth of operations that Aurora has, there’s much more room for Namaste to be able to control its costs.

Significant growth potential for CannMart

The stock could be poised to generate some good growth over the years through its website, CannMart, which provides cannabis consumers options to purchase medical marijuana products and accessories online.

In September, the company announced that it would be adding hemp-based skin care products as well. With the growing popularity of CBD wellness products, it’s a terrific opportunity to take advantage of what’s becoming the next big health craze.

Namaste has also recently received its first order from a government agency, when the BC Liquor Distribution Branch ordered pre-rolled cannabis on the CannMart site.

As Namaste builds up its reputation for quality cannabis, there will be ample room for the company to grow its sales. Like  Aurora, CannMart could also see some explosive sales from the 2.0 market, as in October, it received approval to offer cannabis oil concentrates on its website, which will enable it to sell even more products and reach more consumers.

With plenty of growth in the works, Namaste could benefit from significant success from the growing popularity of CannMart, which could send the stock soaring over the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »